Insiders / Bunnage Mark E. / Activity
Activity — Bunnage Mark E.
9 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.19M | -2K -20.13% | 9,668 <0.01% of shares | medium |
| Feb 13, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.11M | -2K -17.68% | 10,631 <0.01% of shares | low |
| Feb 11, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $930.5K | -2K -13.53% | 12,914 <0.01% of shares | medium |
| Feb 18, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $559.9K | -1K -12.23% | 8,486 <0.01% of shares | medium |
| Feb 17, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $537.0K | -1K -8.40% | 12,105 <0.01% of shares | low |
| Feb 10, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $527.9K | -1K -7.02% | 14,935 <0.01% of shares | low |
| Feb 25, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $301.5K | -620 -7.84% | 7,284 <0.01% of shares | medium |
| Feb 24, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $282.3K | -582 -6.86% | 7,904 <0.01% of shares | low |
| Feb 17, 2026 | Grant | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $0 | +3K +24.31% | 13,215 <0.01% of shares | low |